Andrew Chen

Andrew Chen is a seasoned professional in the pharmaceutical industry with extensive experience in clinical operations and product management. Currently serving as a Director at Bayer Pharmaceuticals since March 2017, Andrew has progressed through various managerial roles within the company. Prior experience includes a position as Clinical Team Manager 2 at PRA Health Sciences and an eClinical Product Manager role at ePharmaSolutions, where responsibilities encompassed product feature assessment and development coordination. Andrew's career began at Novartis, where significant contributions included establishing the Business Intelligence department and acting as a Subject Matter Expert for the company's CTMS. Educational background includes a Bachelor's degree in Chemistry with a Business Option from Rutgers University and graduate coursework in Business Intelligence and Analytics from Stevens Institute of Technology.